BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36578494)

  • 1. SOX chemotherapy with anti-PD-1 and iNKT cell immunotherapies for stage IV gastric adenocarcinoma with liver metastases: A case report.
    Li D; Liu M; Wang J; Guo J; Xu N; Lu J
    Front Immunol; 2022; 13():1073094. PubMed ID: 36578494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathological Complete Response Achieved with XELOX Chemotherapy, HIPEC, and Anti-PD-1 Immunotherapy in Stage IV Gastric Adenocarcinoma with Peritoneal Metastasis: A Case Report and Review of the Literature.
    Zhou J; Wang J; Wang W; Sun L; Zhao S; Sun Q; Wang D
    J Gastrointest Cancer; 2024 Apr; ():. PubMed ID: 38676903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion surgery after S-1 plus oxaliplatin combination chemotherapy for advanced gastric cancer with multiple liver metastases.
    Namikawa T; Tsuda S; Fujisawa K; Iwabu J; Uemura S; Tsujii S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    Clin J Gastroenterol; 2018 Aug; 11(4):297-301. PubMed ID: 29500608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver metastases from gastric carcinoma: A Case report and review of the literature.
    Polkowska-Pruszyńska B; Rawicz-Pruszyński K; Ciseł B; Sitarz R; Polkowska G; Krupski W; Polkowski WP
    Curr Probl Cancer; 2017; 41(3):222-230. PubMed ID: 28625333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.
    Wang X; Li S; Sun Y; Li K; Shen X; Xue Y; Liang P; Li G; Chen L; Zhao Q; Li G; Fu W; Liang H; Xin H; Suo J; Fang X; Zheng Z; Xu Z; Chen H; Zhou Y; He Y; Huang H; Zhu L; Yang K; Ji J; Ye Y; Zhang Z; Li F; Wang X; Tian Y; Park S; Chen L
    BMC Cancer; 2021 Jan; 21(1):20. PubMed ID: 33402102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report.
    Matsumoto R; Arigami T; Matsushita D; Okubo K; Tanaka T; Yanagita S; Sasaki K; Noda M; Kita Y; Mori S; Kurahara H; Ohtsuka T
    World J Surg Oncol; 2020 Jul; 18(1):179. PubMed ID: 32693806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
    Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
    [No Abstract]   [Full Text] [Related]  

  • 9. Case report: A case of advanced gastric cancer with multiple skin metastases, with significant relief from immunotherapy.
    Hao W; Chang R; Liu J; Wang Y; Ren M; Xin K; Liu B; Xie J; Yang Y
    Front Immunol; 2024; 15():1356350. PubMed ID: 38500887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The successfully curative treatment of advanced gastric adenocarcinoma with multiple liver metastases and paraaortic lymph node metastases by salvage operation following the biweekly paclitaxel and S-1 combination chemotherapy: a case report.
    Sasaki K; Natsugoe S; Aridome K; Ishigami S; Hokita S; Aikou T
    Hepatogastroenterology; 2007 Dec; 54(80):2421-4. PubMed ID: 18265679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial.
    Al-Batran SE; Homann N; Pauligk C; Illerhaus G; Martens UM; Stoehlmacher J; Schmalenberg H; Luley KB; Prasnikar N; Egger M; Probst S; Messmann H; Moehler M; Fischbach W; Hartmann JT; Mayer F; Höffkes HG; Koenigsmann M; Arnold D; Kraus TW; Grimm K; Berkhoff S; Post S; Jäger E; Bechstein W; Ronellenfitsch U; Mönig S; Hofheinz RD
    JAMA Oncol; 2017 Sep; 3(9):1237-1244. PubMed ID: 28448662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Case of Advanced Gastric Cancer with Synchronous Liver Metastases Responding to Preoperative Combination Chemotherapy with S-1 plus Oxaliplatin(SOX)].
    Ebisui C; Hamano R; Minoji T; Kitahara T; Yanagisawa T; Okamura S; Fukuchi N; Murata K; Yokouchi H; Kinuta M; Ohishi K
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1263-1265. PubMed ID: 29394601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
    Kinoshita J; Fushida S; Tsukada T; Oyama K; Okamoto K; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Ninomiya I; Ohta T
    Eur J Surg Oncol; 2015 Oct; 41(10):1354-60. PubMed ID: 26028256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
    Zhu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1
    Wang J; Cheng X; Jin Y; Xia B; Qin R; Zhang W; Hu H; Mao X; Zhou L; Yan J; Zhang X; Xu J
    Cancer Res Commun; 2023 Jun; 3(6):991-1003. PubMed ID: 37377605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological complete response of synchronous multiple liver metastases associated with advanced gastric cancer to gastrectomy and prompt S-1 treatment in combination with fractional cisplatin: report of a case.
    Nunobe S; Kiyokawa T; Hatao F; Wada I; Shimizu N; Nomura S; Mise Y; Sugawara Y; Kokudo N; Seto Y
    Hepatogastroenterology; 2012; 59(113):307-9. PubMed ID: 22251551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases].
    Meguro E; Kimura T; Noda Y; Matsumoto Y; Irinoda T; Hayakawa Y; Kobayashi M; Takagane A; Hioki J
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):249-52. PubMed ID: 17301537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of metastatic colon carcinoma following curative resection for advanced gastric cancer associated with metastases to the liver and gallbladder].
    Higuchi I; Akiyama Y; Yamamoto M; Tanigawa T; Hasuike Y; Miyamoto M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2422-4. PubMed ID: 25731544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative chemotherapy of locally advanced gastric cancer.
    Rougier P; Lasser P; Ducreux M; Mahjoubi M; Bognel C; Elias D
    Ann Oncol; 1994; 5 Suppl 3():59-68. PubMed ID: 8204531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-PD-1 plus anti-angiogenesis combined with chemotherapy in patients with HER2-negative advanced or metastatic gastric cancer: a multi-institutional retrospective study.
    Xu T; Wang W; Bao R; Xia X; Zhang J; Huang M; Chen X; Wang R; Zhang H; Liu X; Li Q; Shu Y
    J Gastrointest Oncol; 2023 Feb; 14(1):175-186. PubMed ID: 36915465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.